Terms: = Bone cancer AND PPM1D, Wip1, 8493, ENSG00000170836, O15297, WIP1, PP2C-DELTA
10 results:
1. TRPM2-AS promotes the malignancy of osteosarcoma cells by targeting miR-15b-5p/ppm1d axis.
Cai Y; Yang Y; Zhang X; Ma Q; Li M
Cell Cycle; 2022 Apr; 21(8):835-850. PubMed ID: 35100080
[TBL] [Abstract] [Full Text] [Related]
2. A novel assay for screening wip1 phosphatase substrates in nuclear extracts.
Storchova R; Burdova K; Palek M; Medema RH; Macurek L
FEBS J; 2021 Oct; 288(20):6035-6051. PubMed ID: 33982878
[TBL] [Abstract] [Full Text] [Related]
3. ppm1d accelerates proliferation and metastasis of osteosarcoma by activating PKP2.
He XL; Xiao Q; Zhou ZP; Hui CY
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):78-85. PubMed ID: 33506895
[TBL] [Abstract] [Full Text] [Related]
4. ppm1d Knockdown Suppresses Cell Proliferation, Promotes Cell Apoptosis, and Activates p38 MAPK/p53 Signaling Pathway in Acute Myeloid Leukemia.
Li B; Hu J; He D; Chen Q; Liu S; Zhu X; Yu M
Technol Cancer Res Treat; 2020; 19():1533033820942312. PubMed ID: 32691668
[TBL] [Abstract] [Full Text] [Related]
5. ppm1d Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy.
Hsu JI; Dayaram T; Tovy A; De Braekeleer E; Jeong M; Wang F; Zhang J; Heffernan TP; Gera S; Kovacs JJ; Marszalek JR; Bristow C; Yan Y; Garcia-Manero G; Kantarjian H; Vassiliou G; Futreal PA; Donehower LA; Takahashi K; Goodell MA
Cell Stem Cell; 2018 Nov; 23(5):700-713.e6. PubMed ID: 30388424
[TBL] [Abstract] [Full Text] [Related]
6. P65-mediated miR-590 inhibition modulates the chemoresistance of osteosarcoma to doxorubicin through targeting wild-type p53-induced phosphatase 1.
Long X; Lin XJ
J Cell Biochem; 2019 Apr; 120(4):5652-5665. PubMed ID: 30387173
[TBL] [Abstract] [Full Text] [Related]
7. A cost and resource utilization analysis of micafungin bridging for hemato-oncological high-risk patients undergoing allogeneic stem cell transplantation.
Heimann SM; Vehreschild MJ; Cornely OA; Franke B; von Bergwelt-Baildon M; Wisplinghoff H; Kron F; Scheid C; Vehreschild JJ
Eur J Haematol; 2015 Jun; 94(6):526-31. PubMed ID: 25310918
[TBL] [Abstract] [Full Text] [Related]
8. Beta-carotene antioxidant use during radiation therapy and prostate cancer outcome in the Physicians' Health Study.
Margalit DN; Kasperzyk JL; Martin NE; Sesso HD; Gaziano JM; Ma J; Stampfer MJ; Mucci LA
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):28-32. PubMed ID: 22079732
[TBL] [Abstract] [Full Text] [Related]
9. Oncogenic wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway.
Zhang X; Wan G; Mlotshwa S; Vance V; Berger FG; Chen H; Lu X
Cancer Res; 2010 Sep; 70(18):7176-86. PubMed ID: 20668064
[TBL] [Abstract] [Full Text] [Related]
10. Phosphorylation and degradation of MdmX is inhibited by wip1 phosphatase in the DNA damage response.
Zhang X; Lin L; Guo H; Yang J; Jones SN; Jochemsen A; Lu X
Cancer Res; 2009 Oct; 69(20):7960-8. PubMed ID: 19808970
[TBL] [Abstract] [Full Text] [Related]
